• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

您的位置:首页 >> 制药产品大全 >> 药品制剂 >> Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液

Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液

Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液

更新时间:2020-06-12
地区:江苏省
最小起订量:
月产量:
工厂所在地:China
详细描述
  • 主要销售市场:中/南美洲,亚洲,中东,非洲
  • 提供样品:
产品描述:

INDICATIONS AND USAGE:
Gram-positive Organisms.
Streptococcus pneumoniae,
Streptococcus pyogenes.
Gram-negative Organisms.
Haemophilus influenzae
(beta-lactamase positive and negative strains),
Moraxella (Branhamella) catarrhalis
(most of which are beta-lactamase positive),
Escherichia coli,
Proteus mirabilis,
Neisseria gonorrhoeae
(including penicillinase- and non-penicillinase-producing strains).
Cefixime has been shown to be active in vitro against most strains of the following organisms;
however, clinical efficacy has not been established.
Gram-positive Organisms.
Streptococcus agalactiae .
Gram-negative Organisms.
Haemophilus parainfluenzae
(beta-lactamase positive and negative strains),
Proteus vulgaris,
Klebsiella pneumoniae,
Klebsiella oxytoca,
Pasteurella multocida,
Providencia species,
Salmonella species,
Shigella species,
Citrobacter amalonaticus,
Citrobacter diversus,
Serratia marcescens.
Note: Pseudomonas species, strains of group D streptococci (including enterococci), Listeria
monocytogenes, most strains of staphylococci (including methicillin-resistant strains) and
most strains of Enterobacter are resistant to cefixime. In addition, most strains of Bacteroides
fragilis and Clostridia are resistant to cefixime.

地址:

城市:

联系人:

电话:

传真:

成为供应商 在线获取商机 申请入驻
快速询盘
药品制剂
产品专区头孢克肟
CPHI制药在线为您找到Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液价格、Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液详细参数、Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液相关产品、Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液供应商等信息,想了解当前Cefixime for Oral Suspension 100mg/5ml, 50ml 头孢克肟混悬液最新报价,请联系南京三诺医药科技有限公司
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)